315 related articles for article (PubMed ID: 24583746)
1. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.
Tursi A; Elisei W; Picchio M; Giorgetti GM; Brandimarte G
J Clin Gastroenterol; 2015 Mar; 49(3):218-21. PubMed ID: 24583746
[TBL] [Abstract][Full Text] [Related]
2. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
[TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of advances in the diagnosis of diverticular disease.
Tursi A
Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):791-796. PubMed ID: 29888630
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease.
Maconi G; Dell'Era A; Flor N; De Silvestri A; Lavazza A; Ardizzone S; Bassotti G
Clin Transl Gastroenterol; 2023 Jun; 14(6):e00580. PubMed ID: 36892507
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin in colonic diverticular disease: a case-control study.
Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study.
Tursi A; Elisei W; Franceschi M; Picchio M; Di Mario F; Brandimarte G
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e478-e483. PubMed ID: 33867449
[TBL] [Abstract][Full Text] [Related]
7. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
[TBL] [Abstract][Full Text] [Related]
8. Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.
Alamo RZ; Quigley EMM
Curr Opin Gastroenterol; 2019 Jan; 35(1):27-33. PubMed ID: 30407258
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
David LE; Surdea-Blaga T; Dumitrascu DL
Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537
[TBL] [Abstract][Full Text] [Related]
10. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic challenges of symptomatic uncomplicated diverticular disease.
Cremon C; Bellacosa L; Barbaro MR; Cogliandro RF; Stanghellini V; Barbara G
Minerva Gastroenterol Dietol; 2017 Jun; 63(2):119-129. PubMed ID: 28079347
[TBL] [Abstract][Full Text] [Related]
12. Uncomplicated diverticular disease is not a common cause of colonic symptoms.
Kang JY; Firwana B; Green AE; Matthews H; Poullis A; Barnabas A; Tan LT; Lim AG
Aliment Pharmacol Ther; 2011 Feb; 33(4):487-94. PubMed ID: 21158878
[TBL] [Abstract][Full Text] [Related]
13. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
14. [Non-distinctive abdominal pain: is it diverticular disease or not?].
Frieling T
Dtsch Med Wochenschr; 2024 Mar; 149(7):369-373. PubMed ID: 38479421
[TBL] [Abstract][Full Text] [Related]
15. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management.
Maconi G
Acta Biomed; 2017 Apr; 88(1):25-32. PubMed ID: 28467330
[TBL] [Abstract][Full Text] [Related]
17. Nerve fiber overgrowth in patients with symptomatic diverticular disease.
Barbaro MR; Cremon C; Fuschi D; Scaioli E; Veneziano A; Marasco G; Festi D; Stanghellini V; Barbara G
Neurogastroenterol Motil; 2019 Sep; 31(9):e13575. PubMed ID: 30838745
[TBL] [Abstract][Full Text] [Related]
18. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity.
Pletikosic S; Plavsic I; Hauser G; Tkalcic M
Med Hypotheses; 2015 Sep; 85(3):339-42. PubMed ID: 26112162
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey.
Annibale B; Lahner E; Maconi G; Usai P; Marchi S; Bassotti G; Barbara G; Cuomo R
Int J Colorectal Dis; 2012 Sep; 27(9):1151-9. PubMed ID: 22573184
[TBL] [Abstract][Full Text] [Related]
20. Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients.
Carabotti M; Marasco G; Sbarigia C; Cuomo R; Barbara G; Pace F; Sarnelli G; Annibale B;
Intern Emerg Med; 2024 Apr; ():. PubMed ID: 38671294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
